讨论
美股滚雪球2023-07-03 10:31
玩不下去，做清算也是对股东负责的表现。$Cyteir Therapeutics(CYT)$ 宣布打算停止运营和清算资产后，股价上涨约39%。
根据计划，该公司将寻求出售其所有资产，包括主要候选公司CYT-0851，并在有序结束运营后将剩余现金分配给股东。$香雪制药(SZ300147)$ $双鹭药业(SZ002038)$
简介：Cyteir Therapeutics, Inc.成立于2012年6月4日，是一家特拉华州公司。他们是一家临床阶段的生物技术公司，专注于开发和商业化下一代精确肿瘤药物，通过一种被称为合成致命的治疗策略来抑制DNA损伤修复并导致癌细胞死亡。合成致死率是一种经过临床验证的药物开发方法，当两种条件中的任何一种缺乏时就会出现，这两种条件单独在细胞中是可以耐受的，但在一起是致命的。他们的主要项目CYT-0851，以及下一代候选药物CYT-1853，利用了一种新的功能获得合成致死关系，即DNA损伤基因家族胞苷脱氨酶(CDs)的过度表达与同源重组(HR)的功能抑制之间的关系，同源重组是一种对某些癌症存活至关重要的DNA修复途径。
| 今开： | 昨收：3.02 |
| 最高： | 最低： |
| 涨停价： | 跌停价： |
| 总市值：108714165 |
美股滚雪球2023-07-03 10:31
玩不下去，做清算也是对股东负责的表现。$Cyteir Therapeutics(CYT)$ 宣布打算停止运营和清算资产后，股价上涨约39%。
根据计划，该公司将寻求出售其所有资产，包括主要候选公司CYT-0851，并在有序结束运营后将剩余现金分配给股东。$香雪制药(SZ300147)$ $双鹭药业(SZ002038)$
Cyteir Therapeutics(CYT)03-22 04:25
$Cyteir Therapeutics(CYT)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0000950170-24-034718 Act: 33 Size: 50 KB 网页链接
Cyteir Therapeutics(CYT)03-25 23:15
$Cyteir Therapeutics(CYT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001373604-24-000010 Size: 5 KB 网页链接
Cyteir Therapeutics(CYT)03-22 04:15
$Cyteir Therapeutics(CYT)$ AW Amendment Withdrawal Request Accession Number: 0001193125-24-073844 Act: NE Size: 7 KB 网页链接
Cyteir Therapeutics(CYT)03-22 04:25
$Cyteir Therapeutics(CYT)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0000950170-24-034716 Act: 33 Size: 50 KB 网页链接
Cyteir Therapeutics(CYT)03-22 04:15
$Cyteir Therapeutics(CYT)$ AW Amendment Withdrawal Request Accession Number: 0001193125-24-073839 Act: NE Size: 7 KB 网页链接
Cyteir Therapeutics(CYT)03-22 04:15
$Cyteir Therapeutics(CYT)$ AW Amendment Withdrawal Request Accession Number: 0001193125-24-073836 Act: NE Size: 7 KB 网页链接
Cyteir Therapeutics(CYT)03-22 04:25
$Cyteir Therapeutics(CYT)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0000950170-24-034713 Act: 33 Size: 50 KB 网页链接
Cyteir Therapeutics(CYT)03-20 04:15
$Cyteir Therapeutics(CYT)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001373604-24-000004 Size: 4 KB 网页链接
Cyteir Therapeutics(CYT)03-20 04:35
$Cyteir Therapeutics(CYT)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001373604-24-000008 Act: 34 Size: 80 KB 网页链接
美股滚雪球2023-07-03 10:31
玩不下去，做清算也是对股东负责的表现。$Cyteir Therapeutics(CYT)$ 宣布打算停止运营和清算资产后，股价上涨约39%。
根据计划，该公司将寻求出售其所有资产，包括主要候选公司CYT-0851，并在有序结束运营后将剩余现金分配给股东。$香雪制药(SZ300147)$ $双鹭药业(SZ002038)$查看全文
$Cyteir Therapeutics(CYT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001373604-24-000010 Size: 5 KB 网页链接
$Cyteir Therapeutics(CYT)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0000950170-24-034713 Act: 33 Size: 50 KB 网页链接
$Cyteir Therapeutics(CYT)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0000950170-24-034718 Act: 33 Size: 50 KB 网页链接
$Cyteir Therapeutics(CYT)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0000950170-24-034716 Act: 33 Size: 50 KB 网页链接
$Cyteir Therapeutics(CYT)$ AW Amendment Withdrawal Request Accession Number: 0001193125-24-073836 Act: NE Size: 7 KB 网页链接
$Cyteir Therapeutics(CYT)$ AW Amendment Withdrawal Request Accession Number: 0001193125-24-073839 Act: NE Size: 7 KB 网页链接
$Cyteir Therapeutics(CYT)$ AW Amendment Withdrawal Request Accession Number: 0001193125-24-073844 Act: NE Size: 7 KB 网页链接
$Cyteir Therapeutics(CYT)$ 8-K Current report, items 1.02, 3.03, and 9.01 Accession Number: 0000950170-24-034247 Act: 34 Size: 194 KB 网页链接
$Cyteir Therapeutics(CYT)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001373604-24-000008 Act: 34 Size: 80 KB 网页链接
$Cyteir Therapeutics(CYT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001373604-24-000006 Size: 5 KB 网页链接